Scarica l'app Stockscreener
542.36
4.04%
-22.86
Pre-mercato:
546.21
3.85
+0.71%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$565.22
Aprire:
$563.73
Volume 24 ore:
3.22M
Relative Volume:
1.65
Capitalizzazione di mercato:
$203.77B
Reddito:
$44.56B
Utile/perdita netta:
$6.73B
Rapporto P/E:
30.57
EPS:
17.7391
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-8.41%
1M Prestazione:
-11.26%
6M Prestazione:
+16.28%
1 anno Prestazione:
-6.87%
Intervallo 1D:
$541.34
$566.83
Intervallo di 1 settimana:
$541.34
$588.85
Portata 52W:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
542.36 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
215.75 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
643.59 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
129.64 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
180.96 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Cell Therapy Processing Market to Grow 21.4% Annually Through 2030 - GlobeNewswire Inc.
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex - Endpoints News
OpenAI Unveils Platform to Help Companies Deploy ‘AI Coworkers’ - bloomberg.com
5 Insightful Analyst Questions From Thermo Fisher's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From Thermo Fisher’s Q4 Earnings Call - TradingView
The Zacks Analyst Blog Highlights Alphabet, Apple, Thermo Fisher Scientific and New England Realty Associates - Nasdaq
Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs - Contract Pharma
Thermo Fisher Stock: Can This Life-Science Giant Still Outperform After Its Rebound? - AD HOC NEWS
Premier Path Wealth Partners LLC Has $2.21 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Alta Capital Management LLC - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Hantz Financial Services Inc. - MarketBeat
Thermo Fisher Scientific launches kit to simplify liver cell gene expression and help advance early-stage drug discovery - SelectScience
Thermo Fisher Stock: Quiet Giant Or The Next Breakout In Life Sciences? - AD HOC NEWS
Top Analyst Reports for Alphabet, Apple & Thermo Fisher - TradingView
Major biotech company to lay off dozens of employees, close Mass. facility - MassLive.com
Thermo Fisher to close Franklin MA plant; more than 100 jobs affected - Milford Daily News
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
AGF Management Ltd. Sells 118,109 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Earnings call transcript: Thermo Fisher Q4 2025 earnings beat forecasts - Investing.com
Strengthening Families & Communities LLC Purchases 4,825 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thrivent Financial for Lutherans Sells 13,573 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Peterson Wealth Services Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Earnings call transcript: Thermo Fisher Q4 2025 earnings beat forecasts By Investing.com - Investing.com India
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Jones Financial Companies Lllp - MarketBeat
Pharmacogenomics Market Is Booming Worldwide 2026-2033 | - openPR.com
Synthetic Biology Market Future Business Opportunities - openPR.com
Thermo Fisher Scientific (TMO) Is Down 7.2% After Stronger‑Than‑Expected 2025 Earnings Beat ExpectationsWhat's Changed - simplywall.st
Thermo Fisher Stock: Can A Quiet Healthcare Giant Still Beat The Market? - AD HOC NEWS
Layoff notices hit Massachusetts hard as 260 to lose jobs - Boston Herald
Thermo Fisher to close Franklin site, impacting up to 80 workers - Boston.com
Thermo Fisher Scientific Inc stock nudges higher as Franklin closure plan targets up to 80 layoffs - TechStock²
Thermo Fisher trims Mass. head count with Franklin site closure - Fierce Pharma
Thermo Fisher to close Franklin plant, lay off 80 workers - The Boston Globe
Thermo Fisher to lay off 100, close Franklin facility amid executive shakeup - Worcester Business Journal
Addressing Industry Challenges in Handheld XRF Instrumentation - Spectroscopy Online
3 major companies closing Massachusetts facilities; layoffs to affect about 250 workers - cbsnews.com
Thermo Fisher Scientific’s venture arm brings Massey onboard - Global Venturing
Thermo Fisher Scientific Inc. $TMO Stock Holdings Lessened by Arjuna Capital - MarketBeat
Thermo Fisher Scientific Q4 2025 revenue up 7% to USD 12.21B - Medical Buyer
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - Reuters
Principal Financial Group Inc. Sells 626,401 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Atlantic Union Bankshares Corp Has $20.70 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Exosome Research Market to Witness Stunning Growth 2026-2033 - openPR.com
Veritas Asset Management LLP Has $590.81 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Reworks Operations While Targeting Growth In Clinical Data - simplywall.st
Thermo Fisher Scientific Earnings Call Highlights Steady Growth - The Globe and Mail
Thermo Fisher stock keeps sliding after 2026 outlook — what to watch for TMO this week - TechStock²
Is Thermo Fisher Scientific (TMO) Pricing Reflect Its Recent Share Pullback And DCF Estimate - Yahoo Finance
Bryn Mawr Trust Advisors LLC Cuts Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mediolanum International Funds Ltd Purchases 65,353 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday - TechStock²
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.72%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):